酸盐通过破坏Mfn2-PERK轴介导的内分泌网膜-线粒体相互作用来诱导神经毒性
Yi Zhao1,2,3, Yuan-Hang Chang1, Hao-Ran Ren1
1College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, P. R. China.
Journal of agricultural and food chemistry
|February 23, 2024
概括
甲基二甲基甲酸盐 (DEHP) 通过扰乱大脑内质网膜 (ER) 和线粒体的相互作用而引起神经毒性. 这种酸盐暴露导致运动和认知缺陷,突出了神经疾病的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- -2-乙烯基) 甲酸盐 (DEHP) 是一种常见的塑化剂,具有已知的健康风险.
- 线粒体动力学和内分泌网膜 (ER) 稳态对于线粒体相关的ER膜 (MAM) 完整性至关重要.
研究的目的:
- 为了研究DEHP的神经毒性作用.
- 探索DEHP暴露与ER-线粒体相互作用之间的关联.
主要方法:
- 评估了DEHP对大脑形态,运动功能,认知能力和血脑屏障完整性的影响.
- 研究了DEHP诱导的ER压力通过蛋白质激酶R类内细胞网膜激酶 (PERK) 信号传递.
- 研究了线粒体-2 (Mfn2) 在DEHP诱导的线粒体动力学失衡和MAM损伤中的作用.
主要成果:
- 暴露于DEHP诱导了形态大脑变化,运动缺陷,认知障碍和血脑屏障的破坏.
- DEHP触发了PERK信号介导的ER压力.
- 通过抑制Mfn2-PERK相互作用,DEHP降低了Mfn2的调节,扰乱了线粒体动态,并损害了MAMs.
结论:
- DEHP诱导的神经毒性与Mfn2-PERK轴介导的ER-线粒体相互作用的破坏有关.
- 这一途径为因甲酸盐暴露引起的神经疾病提供了潜在的治疗点.
关键词:
Mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2mfn2佩克 (Perk) 是一种可怕的东西.乙二甲二甲二甲二甲二甲二甲二甲二甲二甲二甲线粒体关联的内细胞网膜膜.神经毒性的作用.更多相关视频
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
6.0K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
相关概念视频
Enzyme-linked Receptors
78.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.4K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
